Literature DB >> 9308979

Myoadenylate deaminase deficiency, hypertrophic cardiomyopathy and gigantism syndrome.

M L Skyllouriotis1, M Marx, R E Bittner, P Skyllouriotis, M Gross, M Wimmer.   

Abstract

We report a 20-year-old man with gigantism syndrome, hypertrophic cardiomyopathy, muscle weakness, exercise intolerance, and severe psychomotor retardation since childhood. Histochemical and biochemical analysis of skeletal muscle biopsy revealed myoadenylate deaminase deficiency; molecular genetic analysis confirmed the diagnosis of primary (inherited) myoadenylate deaminase deficiency. Plasma, urine, and muscle carnitine concentrations were reduced. L-Carnitine treatment led to gradual improvement in exercise tolerance and cognitive performance; plasma and tissue carnitine levels returned to normal, and echocardiographic evidence of left ventricular hypertrophy disappeared. The combination of inherited myoadenylate deaminase deficiency, gigantism syndrome and carnitine deficiency has not previously been described.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9308979     DOI: 10.1016/s0887-8994(97)00076-3

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  1 in total

1.  Right ventricular obstructive hypertrophic cardiomyopathy in primary myo-adenylate deaminase deficiency.

Authors:  C de Gregorio; G Morabito; O Musumeci; R Donato; A Toscano
Journal:  Acta Myol       Date:  2011-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.